Paid Clinical Trials in Louisiana

Browse 99 Paid Studies Louisiana Across 1012 Cities
52 Phase 3 Trial · 5290 Paid Studies Louisiana Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in Louisiana

Reviewed by Michael Gill, B. Sc.

Image of Research site - Orange City in Orange City, United States.

Verified

10 Paid Studies Louisiana Near Me

Top Cities for Paid Studies Louisiana

Los Angeles

80Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site

Anchorage

68Active Trials

Katmai Oncology GroupTop Active Site

Paid Studies Louisiana by Phase of Trial

N/A Paid Studies Louisiana

10Active Paid Studies Louisiana

10Number of Unique Treatments

175Number of Active Locations

Patient arm Boston Scientific WaveWriter SCS System Multimodal intervention strategy Immulina TM NovoSorb BTM Portico transcatheter aortic valve Duodenal Mucosal Resurfacing (DMR)CBT while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline)HIVD+/R+WaveWriter

Most Recent Paid Studies Louisiana

Clinical Trial

Began Recruiting Date

Phase

Relugolix Combination Tablet for Endometriosis

9/14/2023

Phase 3

CBT while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) for Migraine

8/22/2023

N/A

Phase 1b for Non-Hodgkin's Lymphoma

8/4/2023

Phase 1 & 2

Difelikefalin 1.0 mg tablets for Itching

8/1/2023

Phase 2 & 3

Immulina TM for Long COVID Syndrome

7/20/2023

N/A

About The Author

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: August 26th, 2023

References¹ Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. Review. https://pubmed.ncbi.nlm.nih.gov/31401903² Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. https://pubmed.ncbi.nlm.nih.gov/31401903³ O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12(12):CD013756. doi: 10.1002/14651858.CD013756.pub2. https://pubmed.ncbi.nlm.nih.gov/34854473⁴ O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12:CD013756. doi: 10.1002/14651858.CD013756.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/34854473⁵ Kirson ED, Dbalý V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Schneiderman R, Wasserman Y, Salzberg M, Ryffel B, Goldsher D, Dekel E, Palti Y. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10152-7. Epub 2007 Jun 5. https://pubmed.ncbi.nlm.nih.gov/17551011⁶ Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, Wasserman Y, Schatzberger R, Palti Y. Disruption of cancer cell replication by alternating electric fields. Cancer Res. 2004 May 1;64(9):3288-95. https://pubmed.ncbi.nlm.nih.gov/15126372⁷ Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, Wasserman Y, Schatzberger R, Palti Y. Disruption of cancer cell replication by alternating electric fields. Cancer Res. 2004 May 1;64(9):3288-95. doi: 10.1158/0008-5472.can-04-0083. https://pubmed.ncbi.nlm.nih.gov/15126372⁸ Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Schneiderman R, Wasserman Y, Salzberg M, Ryffel B, Goldsher D, Dekel E, Palti Y. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10152-7. doi: 10.1073/pnas.0702916104. Epub 2007 Jun 5. https://pubmed.ncbi.nlm.nih.gov/17551011⁹ Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012 Sep;48(14):2192-202. doi: 10.1016/j.ejca.2012.04.011. Epub 2012 May 18. https://pubmed.ncbi.nlm.nih.gov/22608262¹⁰ Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012 Sep;48(14):2192-202. doi: 10.1016/j.ejca.2012.04.011. Epub 2012 May 18. https://pubmed.ncbi.nlm.nih.gov/22608262